• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Spero Therapeutics, Inc. - Common Stock (NQ:SPRO)

2.570 -0.030 (-1.15%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 284,606
Open 2.590
Bid (Size) 2.470 (400)
Ask (Size) 2.600 (5,000)
Prev. Close 2.600
Today's Range 2.510 - 2.600
52wk Range 0.5052 - 3.220
Shares Outstanding 52,571,813
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Spero Therapeutics Inc (NASDAQ:SPRO) Posts Q3 Revenue and EPS Beat ↗
November 13, 2025
Spero Therapeutics (SPRO) smashed Q3 2025 earnings, with revenue of $5.44M beating $0 estimates and a narrower EPS loss of -$0.13. 
Via Chartmill
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
 
Via Benzinga

Performance

YTD
+9.4%
+9.4%
1 Month
+11.3%
+11.3%
3 Month
+12.7%
+12.7%
6 Month
-15.5%
-15.5%
1 Year
+144.8%
+144.8%

More News

Read More
News headline image
Insights Ahead: Spero Therapeutics's Quarterly Earnings ↗
November 12, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
August 12, 2025
Via Benzinga
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
August 12, 2025
Via Chartmill
News headline image
Earnings Outlook For Spero Therapeutics ↗
August 11, 2025
Via Benzinga
News headline image
An Overview of Spero Therapeutics's Earnings ↗
May 12, 2025
Via Benzinga
News headline image
SPERO THERAPEUTICS INC (NASDAQ:SPRO) Reports Mixed Q2 2025 Results with Revenue Beat but Stock Decline ↗
August 12, 2025
Via Chartmill
News headline image
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields ↗
June 09, 2025
Via Benzinga
News headline image
Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May ↗
May 31, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
May 30, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 12, 2025 ↗
August 12, 2025
Via Benzinga
News headline image
Unusual volume stocks in Friday's session ↗
May 30, 2025
Via Chartmill
News headline image
The trading volume of these stocks is deviating from the norm in today's session. ↗
May 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
May 28, 2025
Via Benzinga
News headline image
These stocks are making the most noise in today's session. ↗
May 28, 2025
Via Chartmill
News headline image
Small-Cap Movers Under $1: HIT, SPRO, SGN, PRSO, SGBX Drive Momentum Across AI, Biotech, Crypto, Software, Etc.
May 28, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
May 28, 2025
Via Benzinga
News headline image
Crude Oil Gains 2%; Macy's Lowers Earnings Forecast ↗
May 28, 2025
Via Benzinga
News headline image
Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday? ↗
May 28, 2025
Via Benzinga
News headline image
US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings ↗
May 28, 2025
Via Benzinga
News headline image
GSK, Spero Therapeutics Stop Antibiotic Trial For Complicated Urinary Tract Infections Early After Positive Results, Retail’s Thrilled ↗
May 28, 2025
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
May 28, 2025
Via Benzinga
News headline image
Earnings Scheduled For March 27, 2025 ↗
March 27, 2025
Via Benzinga
News headline image
Earnings Scheduled For May 13, 2025 ↗
May 13, 2025
Via Benzinga

Frequently Asked Questions

Is Spero Therapeutics, Inc. - Common Stock publicly traded?
Yes, Spero Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Spero Therapeutics, Inc. - Common Stock trade on?
Spero Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Spero Therapeutics, Inc. - Common Stock?
The ticker symbol for Spero Therapeutics, Inc. - Common Stock is SPRO on the Nasdaq Stock Market
What is the current price of Spero Therapeutics, Inc. - Common Stock?
The current price of Spero Therapeutics, Inc. - Common Stock is 2.570
When was Spero Therapeutics, Inc. - Common Stock last traded?
The last trade of Spero Therapeutics, Inc. - Common Stock was at 01/08/26 04:00 PM ET
What is the market capitalization of Spero Therapeutics, Inc. - Common Stock?
The market capitalization of Spero Therapeutics, Inc. - Common Stock is 135.11M
How many shares of Spero Therapeutics, Inc. - Common Stock are outstanding?
Spero Therapeutics, Inc. - Common Stock has 135M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap